Mesa Laboratories (MLAB) Cash from Operations (2010 - 2026)

Mesa Laboratories has disclosed Cash from Operations across 17 years of filings, most recently posting $14.7 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 678.45% year-over-year to $14.7 million; the TTM figure through Jun 2026 stood at $55.7 million (up 46.67% YoY), while the FY2026 annual figure was $42.8 million, down 8.5% from the prior year.
• Cash from Operations came in at $14.7 million for Q2 2026 at Mesa Laboratories, up from $14.0 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $18.8 million in Q4 2025 to a low of -$2.8 million in Q2 2022.
• Average Cash from Operations over 5 years is $10.3 million, with a median of $10.6 million recorded in 2022.
• Year-over-year, Cash from Operations plunged 129.31% in 2022 and soared 678.45% in 2026.
• Over 5 years, Cash from Operations stood at $7.7 million in 2022, then jumped by 49.46% to $11.5 million in 2023, then jumped by 57.17% to $18.1 million in 2024, then increased by 3.45% to $18.8 million in 2025, then retreated by 21.42% to $14.7 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $14.7 million in Q2 2026, $14.0 million in Q1 2026, and $18.8 million in Q4 2025.